ADC Drug DS-8201 Shows Strong Efficacy in Patients with Low HER2 Breast Cancer Expression
Breast cancer is the most common cancer and cause of death among women. About 20% of breast cancers are HER2-positive (IHC3+ or IHC2+/ISH+), and the remaining 80% are HER2-negative. HER2 is aRead More…